Drug delivery is a term that refers to the delivery of a pharmaceutical compound into the body. Most common methods of delivery include the preferred non-invasive oral (through the mouth), nasal, pneumonial (inhalation), and rectal routes. Much research is now focussing on nanotechnology as a drug delivery method.
Nanotechnology has made another breakthrough at the University of California San Diego. For the first time the researchers have shown that micromotors or microscopic robots could be used to treat a bacterial infection in the stomach in mice models win the laboratory.
Vijaya B. Kolachalama, PhD, assistant professor of medicine at Boston University School of Medicine, has received a Scientist Development grant from the American Heart Association.
Chapman University’s four-year-old School of Pharmacy continues its aggressive growth in federal grant awards.
According to latest research, gold particles can be effective in certain cancer therapy areas. Researchers at the Edinburgh University report in their new study that gold particles can help enhance the effectiveness of the agents used for lung cancer cells. The study is published in the scientific journal Angewandte Chemie.
Researchers in Georgia State University's Institute for Biomedical Sciences have received a four-year, $1.4 million federal grant to study novel therapeutic approaches for the treatment of intestinal inflammation.
Ultrasound brain surgery has enormous potential for the treatment of neurological diseases and cancers, but getting sound waves through the skull and into the brain is no easy task.
Many diseases are treated with protein-based drugs. However, due to the size of the molecules, the only effective delivery method is through injection, which can suffer from low patient compliance.
Theoretical physicists led by Professor Kurt Binder and Dr. Arash Nikoubashman at Johannes Gutenberg University Mainz in Germany have used computer simulations to study the arrangement of stiff polymers in spherical cavities.
Around half of all medications for chronic diseases are not taken as prescribed, costing the U.S. health care system more than $100 billion in avoidable hospital stays each year.
The highest priority research agendas needed to improve the testing and treatment of children and adolescents with HIV were presented at the 9th International Aids Society (IAS) Conference on HIV Science in Paris this weekend.
Avantor, a global supplier of ultra-high-purity materials for customers across the life sciences and advanced technologies sectors, has opened a new research center in Bridgewater, New Jersey (USA) to help biopharmaceutical and pharmaceutical customers with a full range of upstream and downstream processes, from gene to protein expression through final formulation and drug delivery.
Nemaura Pharma, the fast-growing UK medical technology company, is a finalist in the Medilink UK industry awards having received the Medilink East Midlands Innovation award for its unique transdermal drug delivery technologies.
To enhance the visibility of organs as they are scanned with magnetic resonance imaging (MRI), patients are usually injected with a compound known as a contrast agent before going into the scanner. The most commonly used MRI contrast agents are based on the metal gadolinium; however, these metal compounds can be harmful for young children or people with kidney problems.
RMIT University scientists in Melbourne, Australia, have led an international collaboration that potentially unlocks better treatment of viral diseases, including the flu and common cold.
Researchers at Okayama University describe in Acta Biomaterialia a new type of biocompatible adhesive material. The adhesive, made from nanoparticles of hydroxyapatite, glues both synthetic hydrogels and mouse soft tissue, providing a promising alternative to organic materials currently in use for clinical applications.
Nicole F. Steinmetz, PhD, George J. Picha Professor in Biomaterials, member of the Case Comprehensive Cancer Center, and Director of the Center for Bio-Nanotechnology at Case Western Reserve School of Medicine, has received two major grants from the National Institutes of Health to develop microscopic drug-delivery systems for patients living with breast cancer, and patients at risk for serious blood clots.
Many potent anti-cancer drugs have major drawbacks -- they fail to mix with water, which means they will have a limited solubility in blood, and they lack selectivity to cancer cells.
Researchers from Case Western Reserve University School of Medicine in collaboration with researchers from Dartmouth Geisel School of Medicine and RWTH Aachen University have adapted virus particles- that normally infect potatoes- to serve as cancer drug delivery devices for mice.
It's possible to alter the wettability of your skin using an ingredient commonly found in cosmetic cleaners, according to new research from Binghamton University, State University of New York.
Photodynamic therapy is often used to treat brain tumors because of its specificity—it can target very small regions containing cancerous cells while sparing the normal cells around it from damage. It works by injecting a drug called a photosensitizer into the bloodstream, where it gathers in cells, and then exposing the drug-filled cells to light.